FG
AHCO icon

Formula Growth’s AdaptHealth AHCO Stock Holding History

Formula Growth’s Portfolio AHCO Stock Details AHCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-60,000
Closed -$2.21M – 150
2021
Q1 		$2.21M Buy
60,000
+10,000
+20% +$353K 0.32% 95
2020
Q4 		$1.88M Hold
50,000
– – 0.31% 83
2020
Q3 		$1.09M Buy
+50,000
New +$1.05M 0.2% 113

Other funds holding AHCO

OCA
OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Formula Growth's AHCO Position: Q2 2021 in Review

Formula Growth sold out of AdaptHealth (AHCO) in Q2 2021, closing a stake of 60,000 shares — an estimated $2.21M sold.

Formula Growth first reported a position in AHCO in Q3 2020 and held it in 3 quarters. The position peaked at $2.21M in Q1 2021. 137 funds tracked by Wall St. Rank hold AHCO as of Q2 2021.

  • Formula Growth reported no remaining AdaptHealth position as of Q2 2021 after selling out during the quarter.
  • Formula Growth sold 60,000 AdaptHealth shares in Q2 2021, an estimated $2.21M.
  • Formula Growth first reported a position in AdaptHealth in Q3 2020 and held it in 3 quarters.
  • Formula Growth's AdaptHealth position peaked at $2.21M in Q1 2021.
  • 137 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2021.

Based on Formula Growth's 13F filing for Q2 2021, filed 13 Aug 2021.